Dose, Safety, and Pathogenicity of a New Influenza B Strain
Clinical trial NCT06254820 · UNKNOWN
Trial details
- NCT number
- NCT06254820
- Sponsor
- Hvivo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-03
- Primary completion
- 2024-02-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.